Overview

Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)

Status:
Suspended
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and dosing of an intravenous (IV) infusion of clevidipine for blood pressure (BP) management in pediatric participants in the perioperative setting.
Phase:
Phase 4
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
The Medicines Company
Treatments:
Clevidipine